AAAAAA
Results: 1-25/64
Authors:
Alberdi, F
Dadone, J
Ryazanov, A
Isenberg, DA
Reichlin, M
Citation: F. Alberdi et al., Cross-reaction of lupus Anti-dsDNA antibodies with protein translation factor EF-2, CLIN IMMUNO, 98(2), 2001, pp. 293-300
Authors:
Alberdi, F
Dadone, J
Ryazanov, A
Isenberg, DA
Ravirajan, C
Reichlin, M
Citation: F. Alberdi et al., Cross-reaction of lupus anti-dsDNA antibodies with protein translation factor EF-2 (vol 98, pg 293, 2001), CLIN IMMUNO, 100(1), 2001, pp. 127-127
Authors:
Moss, KE
Isenberg, DA
Citation: Ke. Moss et Da. Isenberg, Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone, RHEUMATOLOG, 40(8), 2001, pp. 863-867
Authors:
Miller, FW
Rider, LG
Chung, YL
Cooper, R
Danko, K
Farewell, V
Lundberg, I
Morrison, C
Oakley, L
Oakley, I
Pilkington, C
Vencovsky, J
Vincent, K
Scott, DL
Isenberg, DA
Citation: Fw. Miller et al., Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies, RHEUMATOLOG, 40(11), 2001, pp. 1262-1273
Authors:
Sutcliffe, N
Clarke, AE
Taylor, R
Frost, C
Isenberg, DA
Citation: N. Sutcliffe et al., Total costs and predictors of costs in patients with systemic lupus erythematosus, RHEUMATOLOG, 40(1), 2001, pp. 37-47
Authors:
Dayal, NA
Isenberg, DA
Citation: Na. Dayal et Da. Isenberg, Assessment of inflammatory myositis, CURR OP RH, 13(6), 2001, pp. 488-492
Authors:
Salaman, MR
Mawer, DPC
Hogarth, MB
Seifert, MH
Isenberg, DA
Citation: Mr. Salaman et al., Counter-proliferative effects of nucleosomal antigens in cultures from lupus patients, LUPUS, 10(5), 2001, pp. 332-339
Authors:
Isenberg, DA
Gladman, D
Citation: Da. Isenberg et D. Gladman, The Systemic Lupus International Collaborating Clinics group - origins andoutcomes, LUPUS, 10(5), 2001, pp. 375-377
Authors:
Sharma, A
Isenberg, DA
Diamond, B
Citation: A. Sharma et al., Crossreactivity of human anti-dsDNA antibodies to phosphorylcholine: Cluesto their origin, J AUTOIMMUN, 16(4), 2001, pp. 479-484
Authors:
Dean, GS
Isenberg, DA
Citation: Gs. Dean et Da. Isenberg, Detection of anticardiolipin antibodies in culture supernatants, CLIN EXP RH, 19(3), 2001, pp. 251-257
Authors:
Leandro, MJ
Isenberg, DA
Citation: Mj. Leandro et Da. Isenberg, Rheumatic diseases and malignancy - is there an association?, SC J RHEUM, 30(4), 2001, pp. 185-188
Authors:
Isenberg, DA
Karassa, FB
Citation: Da. Isenberg et Fb. Karassa, Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis, N ENG J MED, 344(5), 2001, pp. 382-383
Authors:
Karassa, FB
Isenberg, DA
Citation: Fb. Karassa et Da. Isenberg, Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis (vol 344, pg 382, 2001), N ENG J MED, 344(15), 2001, pp. 1176-1176
Authors:
Kumar, S
Kalsi, J
Latchman, DS
Pearl, LH
Isenberg, DA
Citation: S. Kumar et al., Expression of the fabs of human auto-antibodies in Escherichia coli: Optimization and determination of their fine binding characteristics and cross-reactivity, J MOL BIOL, 308(3), 2001, pp. 527-539
The importance of somatic mutations in the V-lambda gene 2a2 in human monoclonal anti-DNA antibodies
Authors:
Rahman, A
Haley, J
Radway-Bright, E
Nagl, S
Low, DG
Latchman, DS
Isenberg, DA
Citation: A. Rahman et al., The importance of somatic mutations in the V-lambda gene 2a2 in human monoclonal anti-DNA antibodies, J MOL BIOL, 307(1), 2001, pp. 149-160
Authors:
Mason, LJ
Ravirajan, CT
Latchman, DS
Isenberg, DA
Citation: Lj. Mason et al., A human anti-dsDNA monoclonal antibody caused hyaline thrombi formation inkidneys of 'leaky' SCID mice, CLIN EXP IM, 126(1), 2001, pp. 137-142
Authors:
Joseph, JE
Harrison, P
Mackie, IJ
Isenberg, DA
Machin, SJ
Citation: Je. Joseph et al., Increased circulating platelet-leucocyte complexes and platelet activationin patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis, BR J HAEM, 115(2), 2001, pp. 451-459
Authors:
Mediwake, R
Isenberg, DA
Schellekens, GA
van Venrooij, WJ
Citation: R. Mediwake et al., Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis, ANN RHEUM D, 60(1), 2001, pp. 67-68
Authors:
Isenberg, DA
Salmon, M
Citation: Da. Isenberg et M. Salmon, How to supervise a thesis: best practice, HOSP MED, 61(7), 2000, pp. 499-501
Authors:
Herrick, AL
Bradlow, A
Isenberg, DA
Citation: Al. Herrick et al., Regional rheumatology meetings, RHEUMATOLOG, 39(7), 2000, pp. 811-812
Authors:
Isenberg, DA
Salmon, M
Citation: Da. Isenberg et M. Salmon, How to supervise a thesis - best practice, RHEUMATOLOG, 39(5), 2000, pp. 560-562
Authors:
Radway-Bright, EL
Ravirajan, CT
Isenberg, DA
Citation: El. Radway-bright et al., The prevalence of antibodies to anionic phospholipids in patients with theprimary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses, RHEUMATOLOG, 39(4), 2000, pp. 427-431
Authors:
Sutcliffe, N
Smith, C
Speight, PM
Isenberg, DA
Citation: N. Sutcliffe et al., Mucosa-associated lymphoid tissue lymphomas in two patients with rheumatoid arthritis on second-line agents, and secondary Sjogren's syndrome, RHEUMATOLOG, 39(2), 2000, pp. 185-188
Authors:
Frampton, G
Moriya, S
Pearson, JD
Isenberg, DA
Ward, FJ
Smith, TA
Panayiotou, A
Staines, NA
Murphy, JJ
Citation: G. Frampton et al., Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen, RHEUMATOLOG, 39(10), 2000, pp. 1114-1120
Authors:
Sultan, SM
Ioannou, Y
Isenberg, DA
Citation: Sm. Sultan et al., Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review, RHEUMATOLOG, 39(10), 2000, pp. 1147-1152